KR20090119897A - 점막의 질환으로 인한 조직 악화, 상처 또는 손상을 치료 또는 예방하는 방법 - Google Patents
점막의 질환으로 인한 조직 악화, 상처 또는 손상을 치료 또는 예방하는 방법 Download PDFInfo
- Publication number
- KR20090119897A KR20090119897A KR1020097018913A KR20097018913A KR20090119897A KR 20090119897 A KR20090119897 A KR 20090119897A KR 1020097018913 A KR1020097018913 A KR 1020097018913A KR 20097018913 A KR20097018913 A KR 20097018913A KR 20090119897 A KR20090119897 A KR 20090119897A
- Authority
- KR
- South Korea
- Prior art keywords
- days
- mucositis
- scv
- day
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90097707P | 2007-02-13 | 2007-02-13 | |
| US60/900,977 | 2007-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090119897A true KR20090119897A (ko) | 2009-11-20 |
Family
ID=39690681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020097018913A Withdrawn KR20090119897A (ko) | 2007-02-13 | 2008-02-11 | 점막의 질환으로 인한 조직 악화, 상처 또는 손상을 치료 또는 예방하는 방법 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7906486B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2120986A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010518160A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090119897A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101657210A (cg-RX-API-DMAC7.html) |
| AR (1) | AR065338A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008216799A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2677749A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL200364A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009008641A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ579570A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200845958A (cg-RX-API-DMAC7.html) |
| UA (1) | UA96980C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008100458A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009008641A (es) * | 2007-02-13 | 2009-09-14 | Sciclone Pharmaceuticals Inc | Composiciones para el tratamiento o prevencion del deterioro, lesion o daño a tejido debido a enfermedad de las mucosas. |
| RU2436587C1 (ru) * | 2010-10-21 | 2011-12-20 | Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") | N-изовалероил-l-глутамил-l-триптофан как средство, препятствующее язвообразованию в желудке и двенадцатиперстной кишке |
| CN109528202B (zh) * | 2018-11-14 | 2021-07-16 | 北京大学第一医院 | 一种头颈部放疗诊疗系统 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4125626A (en) | 1977-01-17 | 1978-11-14 | Mt. Sinai School Of Medicine Of The City University Of New York | Synthesis and use of L-γ-glutamyl-DOPA |
| US4568489A (en) | 1984-06-29 | 1986-02-04 | E. R. Squibb & Sons, Inc. | N-Acyl-γ-glutamyl imino and amino acids and esters |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4758551A (en) | 1986-07-08 | 1988-07-19 | Cornell Research Foundation, Inc. | Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types |
| US4968672A (en) | 1987-01-02 | 1990-11-06 | The United States Of America As Represented By The Department Of Health And Human Services | Adenosine receptor prodrugs |
| US4895835A (en) | 1987-11-20 | 1990-01-23 | Nisshin Oil Mills, Ltd. | Muramyl peptide derivatives and use thereof |
| US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
| US5902790A (en) | 1995-10-03 | 1999-05-11 | Cytran, Inc. | Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
| US5206220A (en) | 1990-04-23 | 1993-04-27 | Research Corporation Technologies, Inc. | Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition |
| WO1992017191A1 (en) | 1991-04-01 | 1992-10-15 | Cytoven | Pharmaceutical dipeptide compositions and methods of use thereof |
| DE69230500D1 (de) | 1991-10-28 | 2000-02-03 | Cytran Ltd | Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden. |
| AU6359594A (en) | 1993-03-04 | 1994-09-26 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
| GB9320820D0 (en) | 1993-10-08 | 1993-12-01 | Biokine Tech Ltd | Compounds for medicinal use |
| RU2107692C1 (ru) | 1995-06-07 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
| US5888980A (en) | 1994-06-30 | 1999-03-30 | Bio-Logic Research And Development Corporation | Compositions for enhancing immune function |
| WO1997019691A1 (en) | 1995-11-28 | 1997-06-05 | Wei, Edward, T. | Gamma-l-glutamyl containing immunomodulator compounds and methods therewith |
| US5744452A (en) | 1995-11-28 | 1998-04-28 | Edward T. Wei | γ-L-glutamyl containing immunomodulator compounds and methods therewith |
| RU2120298C1 (ru) | 1995-11-28 | 1998-10-20 | Товарищество с ограниченной ответственностью "Верта" | Иммуностимулятор и препарат на его основе |
| US5916878A (en) | 1995-11-28 | 1999-06-29 | Edward T. Wei | γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith |
| US6060452A (en) | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
| RU2141483C1 (ru) | 1997-07-04 | 1999-11-20 | Небольсин Владимир Евгеньевич | Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция |
| RU2229892C2 (ru) | 2001-06-08 | 2004-06-10 | Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" | Способ лечения туберкулеза легких |
| US7173013B2 (en) | 2001-06-08 | 2007-02-06 | Sciclone Pharmaceuticals, Inc. | Treatment of tuberculosis using immunomodulator compounds |
| US20050256042A1 (en) * | 2003-05-09 | 2005-11-17 | Jeffers Michael E | Methods of preventing and treating alimentary mucositis |
| MXPA06013050A (es) * | 2004-05-14 | 2007-03-28 | Sciclone Pharmaceuticals Inc | Composiciones a base de compuestos inmunoreguladores para el tratamiento o prevencion de infecciones virales respiratorias. |
| AU2005299609A1 (en) | 2004-10-27 | 2006-05-04 | Sciclone Pharmaceuticals, Inc. | Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds |
| WO2006076169A2 (en) | 2004-12-28 | 2006-07-20 | Sciclone Pharmaceuticals, Inc. | Treatment or prevention of genital viral infections with immunomodulator compounds |
| US20090074815A1 (en) | 2005-04-22 | 2009-03-19 | Sciclone Pharmaceuticals, Inc. | Immunomodulator Compounds as Vaccine Enhancers |
| CA2649575A1 (en) | 2006-04-20 | 2007-11-01 | Sciclone Pharmaceuticals, Inc. | Treatment of melanoma |
| KR20090094145A (ko) | 2006-12-18 | 2009-09-03 | 아칠리온 파르마세우티칼스 인코포레이티드 | C형 간염 감염을 치료하기 위한 병용 요법 |
| MX2009008641A (es) * | 2007-02-13 | 2009-09-14 | Sciclone Pharmaceuticals Inc | Composiciones para el tratamiento o prevencion del deterioro, lesion o daño a tejido debido a enfermedad de las mucosas. |
| RU2007118237A (ru) | 2007-05-17 | 2008-11-27 | ООО "Научно-производственна фирма Верта" (RU) | Способ лечения аллергических заболеваний |
| UA98508C2 (ru) | 2007-08-23 | 2012-05-25 | Сайклон Фармасьютикалз, Инк. | Иммуномодуляторное производное дипептида для лечения рака легких |
| JP2011530519A (ja) | 2008-08-06 | 2011-12-22 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | 免疫調節化合物を用いたc型肝炎の治療または予防の方法 |
-
2008
- 2008-02-11 MX MX2009008641A patent/MX2009008641A/es not_active Application Discontinuation
- 2008-02-11 UA UAA200909229A patent/UA96980C2/ru unknown
- 2008-02-11 WO PCT/US2008/001768 patent/WO2008100458A2/en not_active Ceased
- 2008-02-11 US US12/526,585 patent/US7906486B2/en not_active Expired - Fee Related
- 2008-02-11 JP JP2009549595A patent/JP2010518160A/ja not_active Withdrawn
- 2008-02-11 CA CA002677749A patent/CA2677749A1/en not_active Abandoned
- 2008-02-11 EP EP08725404A patent/EP2120986A4/en not_active Withdrawn
- 2008-02-11 NZ NZ579570A patent/NZ579570A/en not_active IP Right Cessation
- 2008-02-11 CN CN200880011935A patent/CN101657210A/zh active Pending
- 2008-02-11 KR KR1020097018913A patent/KR20090119897A/ko not_active Withdrawn
- 2008-02-11 AU AU2008216799A patent/AU2008216799A1/en not_active Abandoned
- 2008-02-13 TW TW097105084A patent/TW200845958A/zh unknown
- 2008-02-13 AR ARP080100621A patent/AR065338A1/es not_active Application Discontinuation
-
2009
- 2009-08-12 IL IL200364A patent/IL200364A0/en unknown
-
2011
- 2011-01-25 US US13/013,340 patent/US20110117211A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL200364A0 (en) | 2010-04-29 |
| AU2008216799A1 (en) | 2008-08-21 |
| MX2009008641A (es) | 2009-09-14 |
| WO2008100458A3 (en) | 2008-11-27 |
| JP2010518160A (ja) | 2010-05-27 |
| EP2120986A2 (en) | 2009-11-25 |
| US20100086622A1 (en) | 2010-04-08 |
| AR065338A1 (es) | 2009-06-03 |
| NZ579570A (en) | 2012-02-24 |
| WO2008100458A2 (en) | 2008-08-21 |
| CN101657210A (zh) | 2010-02-24 |
| US7906486B2 (en) | 2011-03-15 |
| US20110117211A1 (en) | 2011-05-19 |
| UA96980C2 (ru) | 2011-12-26 |
| TW200845958A (en) | 2008-12-01 |
| EP2120986A4 (en) | 2010-04-07 |
| CA2677749A1 (en) | 2008-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2235499T3 (es) | Uso de derivados de propionil l-carnitina y de acetil l-carnitina en la preparacion de medicamentos con actividad anticancerigena. | |
| TWI306028B (en) | A combination comprising combretastatin and anticancer agnets | |
| EP2185581B1 (en) | Methods and compositions useful in the treatment of mucositis | |
| KR20180100309A (ko) | 데옥시콜산 및 이의 염을 사용한 축적된 지방의 치료 방법 | |
| CN116726021B (zh) | 一种drp1抑制剂和铁死亡诱导剂联合用药物及其抗肿瘤的用途 | |
| US12311024B2 (en) | Cancer cell-targeted drug delivery carrier and composition for promoting photo-thermal treatment effects, both of which contain M1 macrophages as active ingredient | |
| EP2230908A1 (en) | Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa) | |
| US5964224A (en) | Method for treating amyotrophic lateral sclerosis and a therapeutic agent therefor | |
| US7906486B2 (en) | Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa | |
| ES2351665T3 (es) | Derivados de benzamidina para el tratamiento y la prevención de mucositis. | |
| WO2026020979A1 (zh) | 一种药物组合物及其应用 | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| US20090088392A1 (en) | Treatment of melanoma | |
| CN113150067B (zh) | Gsdme抑制剂及其在肿瘤化疗诱导的消化道损伤防治中的用途 | |
| WO2017173308A1 (en) | Radiation mitigator and method of use thereof | |
| RU2721282C2 (ru) | Способ лечения рассеянного склероза (варианты) | |
| KR20050086819A (ko) | 알파 티모신을 사용한 방사능 손상에 대한 보호방법 | |
| JP3022915B2 (ja) | 癌転移抑制剤 | |
| CN111407748A (zh) | 酪醇在制备治疗脑胶质瘤的药物中的应用 | |
| KR100674604B1 (ko) | 싸이클릭다이펩타이드를 주성분으로 하는 방사선 보호제 | |
| CN110141567B (zh) | 黄连素在制备治疗放射性口炎药物中的应用 | |
| ES2316977T3 (es) | Uso de un antagonista de adrenorreceptor alfa2 para el tratamiento de la epilepsia. | |
| Vanuytsel et al. | Mouse Lip Mucosa During Fractionated Irradiation ¹ | |
| US20090105154A1 (en) | Composition for prevention or treatment of gastrointestinal damage | |
| CN121695123A (zh) | 圣草酚在防治脑卒中方面的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20090910 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |